Andrew Hotchkiss

Chief Executive Officer at Draupnir Bio

Summary

Andrew Hotchkiss is a seasoned professional with a distinguished career spanning over 30 years in the pharmaceutical and biotech industry.
He has a strong background in various therapeutic areas such as Anti-Infectives, CNS, Diabetes, Oncology, Bone, Immunology, and Neuro-degeneration.
Andrew's expertise lies in leadership roles encompassing sales, marketing, corporate and commercial strategy, country management, business development, regional leadership positions, digital strategy, and industry trade associations.
His educational background includes studying Biochemistry at Cardiff University / Prifysgol Caerdydd.
Notable positions in his career include Chief Executive Officer at Draupnir Bio, Chief Commercial Officer at Immunocore, President Europe, Australia, and Canada at Eli Lilly and Company, among others.
Andrew Hotchkiss has a wealth of experience in leading organizations and driving growth and innovation in the pharmaceutical and biotech sectors.

Tags

business development digital strategy biochemistry sales and marketing pharmaceutical industry leadership roles commercial strategy biotech industry eli lilly and company therapeutic areas

This public profile is provided courtesy of Clay. All information found here is in the public domain.

Contact Us
About

This public profile is provided courtesy of Clay. All information found here is in the public domain.

Contact Us
About